Product Name:3,5-Difluorobenzonitrile

IUPAC Name:3,5-difluorobenzonitrile

CAS:64248-63-1
Molecular Formula:C7H3F2N
Purity:95%+
Catalog Number:CM158029
Molecular Weight:139.1

Packing Unit Available Stock Price($) Quantity
CM158029-1000g 5 Weeks ȷDzǕ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:64248-63-1
Molecular Formula:C7H3F2N
Melting Point:-
Smiles Code:N#CC1=CC(F)=CC(F)=C1
Density:
Catalog Number:CM158029
Molecular Weight:139.1
Boiling Point:169°C at 760 mmHg
MDL No:MFCD00010311
Storage:Store at room temperature.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Belzutifan
On September 19, MSD announced that the U.S. FDA has accepted and granted priority review for a supplemental new drug application (sNDA) seeking approval for Welireg (Belzutifan), Merck's oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of adult patients with advanced renal cell carcinoma (RCC). Welireg was the first HIF-2α inhibitor therapy approved in the U.S. and is currently approved for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated RCC, central nervous system hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.